The use of endovascular hemostasis to prevent recurrence of ulcerative gastroduodenal bleeding in an emergency hospital-Reference-Cited by-同舟云学术

The use of endovascular hemostasis to prevent recurrence of ulcerative gastroduodenal bleeding in an emergency hospital

Published:2023-11-22 Issue:4 Volume:24 Page:25-31
ISSN:2072-6716
Container-title:EMERGENCY MEDICAL CARE
language:
Short-container-title:Skor. med. pomoŝʹ

Author:

Parfenov A. O.¹^ORCID,Verbitsky V. G.¹^ORCID,Demko A. E.¹^ORCID,Kiselev M. A.²^ORCID,Kandyba D. V.²,Platonov S. A.²

Affiliation:

1. Military Medical Academy named after S. M. Kirov; St. Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine

2. St. Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine

Abstract

According to the Department of ambulance organization of the I. I. Dzhanelidze Research Institute of Joint Venture in the structure of the “acute abdomen” UGDB takes 4th place in 2021. Transcatheter arterial embolization (TAE) is an alternative to palliative surgical interventions when conservative treatment of ulcerative bleeding using endoscopic hemostasis methods is ineffective, especially in patients with a high risk of surgery and an unfavorable outcome. The aim of the work is to evaluate its role in improving the results of treatment of patients with UGDB who underwent TAE in an ambulance hospital in order to prevent recurrence of bleeding, to assess its role in improving the results of treatment of this category of patients. Materials and methods. The analysis of the results of treatment of 30 patients with UGDB who were on inpatient treatment at the I. I. Dzhanelidze Research Institute of SP from 2018 to 2021, the use of TAE is an alternative to open palliative surgery. As a result of the conducted examination, it was found that the use of endovascular hemostasis in order to prevent recurrence of bleeding in a group of somatically severe patients with UGDB is advisable.

Publisher

FSBEI HE I.P. Pavlov SPbSMU MOH Russia

Reference13 articles.

1. Wuerth B.A., Rockey D.C. Changing Epidemiology of Upper Gastrointestinal Hemorrhage in the Last Decade: A Nationwide Analysis // Dig. Dis. Sci. 2018. Vol. 63. P. 1286–1293.

2. Lau J.Y., Sung J., Hill C., Henderson C., Howden C.W., Metz D.C. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality // Digestion. 2011. Vol. 84. Р. 102–113. doi: 10.1159/000323958.

3. Manukovsky V.A., Barsukova I.M., Dubikaitis P.A. Information materials on emergency surgical care for acute surgical diseases of the abdominal organs in St. Petersburg for 2021. St. Petersburg: St. Petersburg Research Institute of Emergency Medicine named after I. I. Dzhanelidze, 2022. 20 p. (In Russ.). EDN DXKVJE.

4. Mashkin A.M., Chesnokov E.V., Efanov A.V. et al. Results of treatment and prevention of peptic ulcer complicated by gastrointestinal bleeding. Surgery in gastroenterology, 2014, Vol. 6, No. 10, pp. 22–25 (In Russ.).

5. Sazhin V. P., Savelyev V. M., Sazhin I. V. et al. Treatment of patients with a high probability of developing relapses of ulcerative gastroduodenal bleeding. Surgery, 2013, No. 7, pp. 20–23 (In Russ.).